ATG16L1 and graft versus host disease: As a target of miR-142-3p, knock-down of this miRNA results in enhanced ATG16L1, leading to augmented autophagy, better suppressive function in vitro and superior tTreg mediated protection of GVHD lethality after in vivo adoptive tTreg cell transfer.